The BBCR mission is to customize strategies, simplify clinical research, design cost-effective trials, streamline protocols, and create a regulatory roadmap. Learn more about our services by visiting bbcrconsulting.com
 – Boston Biotech Clinical Research (BBCR). Strategic Clinical Innovation Experts. Rare Disease, Clinical Trials, Clinical Research, & Biologics. We work with biotech, pharmaceutical, and device companies to develop clinical/regulatory road-maps consisting with simplified clinical programs, streamlined protocols, and cost-effective clinical trials. Our experienced team provides innovative strategies that meet your goals.
 by Boston Biotech Clinical Research | Sep 20, 2022 | Medical Affairs and Clinical Research, Rare Disease, Real World Evidence, Regulatory Affairs, Strategy and TPP
How we can help
- The BBCR team provides knowledge in cell, biologics and gene therapies
 - BBCR addresses sponsors’ questions in the ever-changing regulatory environment
 - We offer clinical strategy for orphan diseases and precision medicine
 - RWE can be used to build orphan diseases evidence to support regulatory decisions
 - BBCR serves small and medium sized Biotech Companies, Venture Capitalists/Investors and Research, Pharma, and Biotech Companies
 
Contact BBCR Today
 

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process.  Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.